Voyager Therapeutics (VYGR) Reports Q4 Loss, Beats Revenue Estimates
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of +15.08% and +57.97%, respectively, for the quarter ended December 2025. Do…
3,969€
1,35%
Echtzeit-Aktienkurs Voyager Therapeutics Inc.
Bid:
Ask:
Nachrichten zur Voyager Therapeutics Inc. Aktie
Voyager Therapeutics, Inc. (VYGR) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript
…
Bragar Eagel & Squire, P.C. Is Investigating Dave, Red Cat, Perpetua, and Voyager and Encourages Investors to Contact the Firm
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Voyager Therapeutics, Inc. (VYGR) Q4 2024 Earnings Call Transcript
…
Voyager Therapeutics stock tumbles after IND application delayed By Investing.com
Voyager Therapeutics stock tumbles after IND application delayed…
Voyager Therapeutics Aktie: Attraktive Einstiegsmöglichkeit
Los Angeles (www.aktiencheck.de) - Voyager Therapeutics-Aktienanalyse von Wedbush Securities:
1. Gründe für die Hochstufung der Aktie von Voyager Therapeutics Inc, (ISIN:…
Voyager Therapeutics Tracer Platform Targets CNS Market: Heres Why Im Neutral
…
Voyager Therapeutics, Inc. (VYGR) Q3 2024 Earnings Call Transcript
…
Voyager Therapeutics, Inc. (VYGR) Q2 2024 Earnings Call Transcript
…
Voyager Therapeutics, Inc. (VYGR) Q1 2024 Earnings Call Transcript
…
Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast
LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to…
Voyager Therapeutics gets new chief medical officer
…
Voyageur Therapeutics executes royalty agreement with Rain Cage Carbon
Voyager Therapeutics Inc (NASDAQ:VYGR) announced that it has executed a royalty agreement with its carbon capture and drug development partner…
Voyager Therapeutics, Inc. (VYGR) Q4 2023 Earnings Call Transcript
…